FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Pfizer Q3 Results - Q3 Top Pharma Company Earnings Reports

Tools

View Pfizer's Q3 Earnings Report

pfizer logoFiercePharma says: The good news: Pfizer delivered a big increase in third-quarter profits; 26 percent, to be exact. The bad: revenues slipped 3 percent, highlighting the fact that cost-cutting boosted earnings, not product performance. (Nonetheless, sales did beat analyst estimates.) Read more of our coverage here...

Highlights:

  • Third-Quarter 2009 Revenues of $11.6 Billion
  • Third-Quarter 2009 Reported Diluted EPS(1) of $0.43, Adjusted Diluted EPS(2) of $0.51
  • Continues to Execute on Financial and Strategic Commitments; Commenced Wyeth Integration on October 16, 2009 Following Completion of the Acquisition
  • Updates Full-Year 2009 Revenue, Reported Diluted EPS(1) and Adjusted Diluted EPS(2) Guidance to Reflect Wyeth Acquisition

Check out Pfizer's current earnings estimates from CNN Money

Pfizer's Website http://www.pfizer.com/home/

Related Articles:
Pfizer/Wyeth merger could eliminate $3B, R&D jobs
Pfizer plans dramatic increase in new cancer drugs
Generics expected to hit Merck, Pfizer earnings
Pfizer moves to cap retiree health benefits


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Pfizer   pharma earnings  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.